A case is presented of a patient who developed acute hepatitis during cholesterol-lowering treatment with atorvastatin and ezetimibe. Further investigations reveal a probable drug-induced autoimmune hepatitis, and ezetimibe is considered to be the most likely causal agent. This case is the first report of an autoimmune hepatitis associated with ezetimibe therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1258/0004563054890105 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!